RECRUITING Not applicable ClinicalTrials.gov

Predictors of Clinical Course and Treatment Response in DBT Programmes

Sponsor: Oslo University Hospital • ClinicalTrials.gov ID: NCT04318899

Registry updated: 2026-10-16

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Description

The project is a collaboration between The National Centre for Suicide Research and Prevention (NSSF) and clinical units with Dialectical Behaviour Therapy (DBT) programmes. A methodological and technological platform has been established that enables clinicians to deliver high quality treatments over extended periods of time, to evaluate their own performance and productivity and to report it in a uniform and systematic way that will enable comparison across clinical settings and programmes. The collected data constitute the basis for conducting the clinical study with the overall aim to study predictors of the clinical course and treatment response in patients admitted to DBT programmes in Norway.

Interventions

Dialectical Behaviour Therapy adapted for adolescents (DBT-A) (Behavioral)
DBT developed by Marsha Linehan (Linehan 1993a; 1993b) and adapted for adolescents (DBT-A) by Miller, Rathus \& Linehan, 2007 consisting of 20 weeks of weekly individual therapy (60 minutes), multifamily skills training (120 minutes), family therapy sessions as needed and telephone coaching outside therapy sessions.
Dialectical Behaviour Therapy - Standard version (DBT) (Behavioral)
DBT developed by Marsha Linehan (Linehan 1993a, 1993 b) consisting of 1 weekly session of individual therapy (60 minutes), 1 weekly session of skills training (120 minutes), and telephone coaching with individual therapists outside therapy sessions as needed.

Eligibility criteria

Inclusion Criteria: * History of repeated deliberate self harm * Satisfies criteria of Diagnostic and Statistical Manual (DSM-IV) Borderline Personality Disorder as measured by Structured Clinical Interview for the DSM (SCID-II) in addition to the self-destructive criterion. Exclusion Criteria: * Psychotic disorders * Anorexia Nervosa * Substance dependence disorder * Mental retardation (IQ less than 70) * Asperger syndrome/autism

Conditions

Self Harm Borderline Personality Disorder

Locations

Søndre Oslo DPS/Oslo Universitetssykehus HF — Oslo, Oslo, Norway
Moss DPS/Østfold sykehus HF — Moss, Norway
Psykiatrisk senter ytre Helgeland/Helgelandssykehuset HF — Sandnessjøen, Norway
Bjerketun behandlingshjem/Vestreviken HF — Sandvika, Norway
BUP Lian/St Olavs Hospital HF — Trondheim, Norway

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record

Accelerate Your Clinical Trial Recruitment